AR069216A1 - Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos - Google Patents

Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos

Info

Publication number
AR069216A1
AR069216A1 ARP080104863A ARP080104863A AR069216A1 AR 069216 A1 AR069216 A1 AR 069216A1 AR P080104863 A ARP080104863 A AR P080104863A AR P080104863 A ARP080104863 A AR P080104863A AR 069216 A1 AR069216 A1 AR 069216A1
Authority
AR
Argentina
Prior art keywords
mycoplasma hyopneumoniae
composition
compositions
live
antigens
Prior art date
Application number
ARP080104863A
Other languages
English (en)
Inventor
Hsien-Jue Chu
Zhichang Xu
Nicole Rae Gibson
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR069216A1 publication Critical patent/AR069216A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Composiciones inmunogénicas y composiciones de vacuna y métodos para su preparacion y uso, dichas composiciones son efectivas para proteger contra, minimizar la severidad de, prevenir y/o mejorar la infeccion por el Mycoplasma hyopneumoniae. La administracion a un animal de una o dos dosis de esta composicion de Mycoplasma hyopneumoniae avirulento vivo adyuvado es efectiva para proporcionar inmunidad al animal y proteccion contra la infeccion con una cepa virulenta de Mycoplasma hyopneumoniae, reduciendo así la severidad de y/o previniendo la enfermedad causada por una o más cepas virulentas del Mycoplasma hyopneumoniae. Algunas composiciones comprenden, además, uno o más antígenos tales como, por ejemplo, una o más bacterias vivas, bacterinas, toxoides y/o virus y/o antígeno viral. Se ha ejemplificado composiciones inmunogénicas que comprenden un Mycoplasma hyopneumoniae avirulento vivo adyuvado y composiciones que comprenden la vacuna viva modificada de la quimera del Circovirus Tipo 1-Tipo 2 Porcina (cPCV1-2) en combinacion adicional con un Mycoplasma hyopneumoniae avirulento vivo adyuvado. Reivindicacion 7: La composicion de cualquiera de las reivindicaciones 1 a 6, caracterizada porque dicho adyuvante biologicamente aceptable se selecciona del grupo que consiste de uno o más entre SL-CD, Carbopol, y SP-Oil. Reivindicacion 12: La composicion de cualquiera de las reivindicaciones 1 a 10, caracterizada porque comprende además uno o más antígenos virales seleccionados del grupo que consiste de un antígeno del virus de influenza porcina (SIV), un antígeno del virus del síndrome reproductivo y respiratorio porcino (PRRSV), el PRRS que expresa el virus de la viruela del mapache y/o otros antígenos, el PRRS que expresa TGEV y/o otros antígenos, y un antígeno de circovirus porcino (PCV). Reivindicacion 20: La composicion de cualquiera de las reivindicaciones 15 a 19, caracterizada porque comprende además una o más bacterias vivas, bacterina y/o una o más toxides purificados seleccionados del grupo que consiste de Haemophilus paraseis, Pasteurella multocida, Streptococcus suis, Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Salmonella choleraesuis, Erysipelothrix rhusiopathiae y la bacteria leptospira.
ARP080104863A 2007-11-06 2008-11-06 Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos AR069216A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98581107P 2007-11-06 2007-11-06

Publications (1)

Publication Number Publication Date
AR069216A1 true AR069216A1 (es) 2010-01-06

Family

ID=40303616

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104863A AR069216A1 (es) 2007-11-06 2008-11-06 Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos

Country Status (20)

Country Link
US (1) US9056909B2 (es)
EP (1) EP2217271B1 (es)
JP (1) JP5869221B2 (es)
KR (1) KR101225304B1 (es)
CN (2) CN104043116A (es)
AR (1) AR069216A1 (es)
AU (1) AU2008324780A1 (es)
BR (1) BRPI0820341B1 (es)
CA (1) CA2704775C (es)
CL (1) CL2008003304A1 (es)
CO (1) CO6270337A2 (es)
DK (1) DK2217271T3 (es)
HK (1) HK1198289A1 (es)
ME (1) ME01000B (es)
MX (1) MX2010005014A (es)
RU (1) RU2489164C9 (es)
TW (1) TWI513463B (es)
UA (1) UA98812C2 (es)
WO (1) WO2009061798A1 (es)
ZA (1) ZA201004026B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
BRPI1010679B1 (pt) * 2009-05-19 2020-09-24 Bioproperties Pty Ltd Cepa de vacina de mycoplasma hyopneumoniae sensível à temperatura e aplicações da mesma, composiçao de vacina, método de preparaçao e uso da mesma
EP2571980A4 (en) * 2010-05-19 2014-02-26 Bioproperties Pty Ltd METHOD RELATED TO A WEAKEN MYCOPLASMA
WO2013131565A1 (en) 2012-03-07 2013-09-12 Ceva Sante Animale Novel veterinary vaccine
CN102988978B (zh) * 2011-08-01 2016-02-03 普莱柯生物工程股份有限公司 含有猪圆环病毒2型抗原与副猪嗜血杆菌抗原的疫苗组合物及其制备方法与应用
CN103083658B (zh) * 2011-10-27 2015-09-02 普莱柯生物工程股份有限公司 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
CN103157100B (zh) * 2011-12-08 2014-09-24 普莱柯生物工程股份有限公司 副猪嗜血杆菌病、猪链球菌病二联灭活疫苗及其制备方法
CN103157104B (zh) * 2011-12-14 2015-11-18 普莱柯生物工程股份有限公司 猪瘟疫苗的硫代硫酸钠稀释液
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
EP2684959A1 (en) * 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途
CN103623400B (zh) * 2012-08-24 2016-08-17 普莱柯生物工程股份有限公司 抗猪支原体肺炎、传染性胸膜肺炎疫苗组合物及制备方法
CN103861095B (zh) * 2012-12-11 2016-03-09 普莱柯生物工程股份有限公司 含猪支原体肺炎抗原和猪链球菌病抗原的疫苗组合物及其制备方法和应用
EA032772B1 (ru) * 2012-12-28 2019-07-31 Бёрингер Ингельхайм Ветмедика Гмбх Способ получения иммуногенной композиции, предназначенной для лечения и/или профилактики вызываемых микоплазмами инфекций у субъекта
WO2014105671A1 (en) 2012-12-28 2014-07-03 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
EP2994162B1 (en) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccine for pcv2 and mycoplasma
CN104338128B (zh) * 2013-07-31 2017-09-05 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
CN105530956A (zh) * 2013-09-05 2016-04-27 硕腾服务有限责任公司 Hendra和Nipah病毒G糖蛋白免疫原性组合物
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10279031B2 (en) * 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
EP3498847A4 (en) * 2016-08-12 2020-03-04 Innovac VACCINE COMPOSITION FOR PREVENTING SWINE MYCOPLASM INFECTION COMPRISING A RECOMBINANT PROTEIN
CN109234418B (zh) * 2018-11-20 2021-08-13 湖南中净生物科技有限公司 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112143666B (zh) * 2020-09-07 2023-02-21 华中农业大学 一种猪肺炎支原体弱毒株及其在制备弱毒疫苗中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917619A (en) 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
JPS5540568B2 (es) * 1972-10-05 1980-10-18
US4567043A (en) 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
FR2565825B1 (fr) 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4894332A (en) 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
JPS62273456A (ja) 1986-05-21 1987-11-27 Tosoh Corp 分析装置用に用いるテストカツプのシ−ル箔破開用シ−ルブレ−カ
JPH0795069B2 (ja) * 1986-05-22 1995-10-11 農林水産省家畜衛生試験場長 マウスＩｇＡ単クローン抗体を用いる豚マイコプラズマ肺炎の診断方法
EP0283840A3 (en) 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0571648A1 (en) 1992-05-26 1993-12-01 Chung-Nan Weng Vaccine protecting against mycoplasmal pneumonia
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
CA2390613A1 (en) 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
US6585981B1 (en) 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
SK288010B6 (sk) * 2001-07-02 2012-10-02 Pfizer Products Inc. Use of Mycoplasma hyopneumoniae for the manufacture of a medicament
CN1612749A (zh) * 2001-07-02 2005-05-04 辉瑞产品公司 用于减弱牲畜体内牛支原体肺炎的猪肺炎支原体疫苗和方法
CA2452545C (en) 2001-07-27 2015-06-09 Wyeth West nile vaccine comprising live attenuated, inactivated or killed whole or subunit west nile virus
US20030129161A1 (en) 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
MXPA04009723A (es) * 2002-04-05 2005-07-14 Univ Iowa State Res Found Inc Polipeptidos de micoplasma.
TWI350174B (en) * 2003-03-12 2011-10-11 Wyeth Corp Adjuvanted bovine vaccines
RU2278704C2 (ru) * 2004-01-12 2006-06-27 Алексей Борисович Башкиров Метод индукции иммунного ответа организма млекопитающих-2

Also Published As

Publication number Publication date
JP5869221B2 (ja) 2016-02-24
US20090117152A1 (en) 2009-05-07
ZA201004026B (en) 2011-04-28
MX2010005014A (es) 2010-06-30
HK1198289A1 (en) 2015-03-27
RU2489164C9 (ru) 2014-01-20
BRPI0820341B1 (pt) 2021-11-09
CA2704775C (en) 2016-05-10
EP2217271B1 (en) 2016-05-04
ME01000B (me) 2012-10-20
CN104043116A (zh) 2014-09-17
WO2009061798A1 (en) 2009-05-14
EP2217271A1 (en) 2010-08-18
CA2704775A1 (en) 2009-05-14
US9056909B2 (en) 2015-06-16
KR20100087202A (ko) 2010-08-03
CL2008003304A1 (es) 2009-01-09
CO6270337A2 (es) 2011-04-20
RU2489164C2 (ru) 2013-08-10
BRPI0820341A2 (pt) 2020-05-19
TW200927166A (en) 2009-07-01
AU2008324780A1 (en) 2009-05-14
CN101883581A (zh) 2010-11-10
JP2011503086A (ja) 2011-01-27
DK2217271T3 (en) 2016-06-06
RU2010117614A (ru) 2011-12-20
UA98812C2 (ru) 2012-06-25
TWI513463B (zh) 2015-12-21
KR101225304B1 (ko) 2013-01-22

Similar Documents

Publication Publication Date Title
AR069216A1 (es) Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos
ES2905302T3 (es) Vacuna de Mycoplasma hyopneumoniae
ECSP20032085A (es) Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y métodos de uso de estos
AR039545A1 (es) Vacuna de bacterina de mycoplasma hyopneumoniae mejorada
JP2015512448A5 (es)
CU20190030A7 (es) Composiciones de vacunas antineumocócicas polivalentes que comprenden conjugados de polisacárido-proteína
JP2015512449A5 (es)
CA2836805C (en) Bovine vaccines and methods
BRPI0821286A8 (pt) Métodos e composições para imunizar porcos contra circovirus suino
RU2014140106A (ru) Комбинированная вакцина pcv/mycoplasma hyopneumoniae
RU2010112939A (ru) Снижение сопутствующих инфекций у свиней с помощью антигена pcv2
JP2014037449A (ja) ローソニア・イントラセルラリスを含む免疫原性組成物
RU2013114405A (ru) Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций
NZ591950A (en) Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
MX2018007950A (es) Vacuna multivalente m hyo y usos de la misma.
AR103427A1 (es) Vacuna contra la fiebre aftosa
CA2646574A1 (en) Vaccine against mycoplasma and prrsv
RU2018137034A (ru) Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
DK3076997T3 (en) SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS
BR112021008646A2 (pt) uma vacina para proteção contra streptococcus suis
WO2016130569A4 (en) A composition comprising pedv antigens and methods for making and using the composition
CA3085535A1 (en) Intradermal combination vaccine against mycoplasma and porcine circovirus
RU2524430C1 (ru) Вакцина для профилактики сибирской язвы и некробактериоза животных и способ получения ее
BR112020011831A2 (pt) vacina para proteção contra streptococcus suis
BRPI0710550A2 (pt) uso de uma dose imunogênica de material imunogênico de mycoplasma hyopneumoniae e uma dose imunogênica de vìrus de prrs atenuado vivo, kit de vacina, e, método para a vacinação de porcos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal